Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Feline hypoalbuminaemia more common than thought, study finds
Feline hypoalbuminaemia could be used as a prognostic indicator.
Study suggests rates are higher than those in dogs.

A new study has challenged the belief that hypoalbuminaemia in cats is uncommon.

Researchers from the Royal (Dick) School of Veterinary Studies discovered that rates of hypoalbuminaemia were higher in cats than they were in dogs.

The study sought to explore the incidence of feline hypoalbuminaemia and its presenting disease categories and pathoaetiologies. The data was compared to previously recorded rates in dogs.

It also hoped to explore the relationship between hypoalbuminaemia and the clinical outcome of diagnoses.

Hypoalbuminaemia can be caused by several different disease processes. Animals which have hypoalbuminaemia may experience impaired wound healing and increased morbidity, as well as higher rates of mortality.
 
There have been numerous studies into hypoalbuminaemia in dogs. It is associated with a variety of diseases and has proven to be a reliable prognostic indicator.

However, hypoalbuminaemia has been poorly researched in cats. The veterinary school says that there is little understanding into the condition’s role as an acute phase protein or its prognostic value.

From their study of 1,632 cats, researchers found that 32.7 per cent of the population had hypoalbuminaemia.

It was also discovered that gastrointestinal diseases, such as gastrointestinal neoplasia, could be closely linked to the condition.

Although researchers say a retrospective study has limitations, the data may indicate that protein-losing enteropathy is more common in cats than thought. It also suggests that albumin is a feline negative acute phase protein.

Furthermore, there is potential for the severity of hypoalbuminaemia to be used as a prognostic indicator, with albumin incorporated in the feline prognostic scoring systems.

Karen Fong, lead author of the study, said: “We hope this study urges dialogue surrounding the topic of feline hypoalbuminaemia and sparks future research.

“We also encourage our colleagues in practice to consider the clinical significance of low albumin in cats, especially when gastrointestinal signs are present.”

The full study can be found in the Journal of the Small Animal Practice.

Image © Shutterstock

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.